U.S. Food and Drug Administration (FDA) · United States
FDA Tobacco Product Advertising (Family Smoking Prevention and Tobacco Control Act)
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth.
What is FDA Tobacco Product Advertising (Family Smoking Prevention and Tobacco Control Act)?
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth. Apply to ads for cigarettes, smokeless tobacco, e-cigarettes and e-liquids, cigars, hookah and nicotine pouches in any channel.
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth.
How can marketing teams comply?
Apply to ads for cigarettes, smokeless tobacco, e-cigarettes and e-liquids, cigars, hookah and nicotine pouches in any channel.
What is FDA Tobacco Product Advertising (Family Smoking Prevention and Tobacco Control Act)?
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth.
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
FDA's food labeling rules require a Nutrition Facts panel and other label elements and restrict nutrient and 'healthy' claims to foods meeting FDA criteria; the amended 'healthy' definition is effective April 28, 2025 with compliance required by Feb. 25, 2028.
Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.
OTC external drug products covered by 21 CFR 358 (warts, corns and calluses, ingrown toenails, lice, dandruff, seborrheic dermatitis, psoriasis) may only claim the uses and actives in their monograph.
FDA food additive rules require additives to be approved or GRAS, and labeling rules require certified colors and preservatives to be declared properly; 'no artificial' or 'no preservative' claims must match the ingredient list.
Food and supplement labels may link a substance to reduced disease risk only through FDA-authorized or qualified health claims, in the required form, and only on foods meeting nutrient eligibility; disease treatment claims are not allowed.
Request a free compliance scan of your homepage and book a time with Warrant.